Pulmonary arteriography in the high-risk patient.
Pulmonary arteriography in the high-risk patient.
复制标题
高危患者的肺动脉造影。
DOI：
10.1148/radiology.162.1.3786760
复制
发表时间：
1987
期刊：
影响因子：
19.7
通讯作者：
N. Dunnick
中科院分区：
文献类型：
--
作者：
L. Perlmutt;S. Braun;G. E. Newman;E. Oke;N. Dunnick
肺动脉造影是一种侵入性但相对安全的诊断方法。一般认为，肺动脉高压的存在是增加主要并发症发生可能性的一个危险因素。为了评估风险的大小，我们回顾性回顾了1434例接受肺动脉造影的患者的报告，并记录了388例（27%）肺动脉高压患者的并发症发生情况。在1,434例检查中，有30例（2%）发生了与造影剂注射相关的主要并发症（不包括过敏反应），其中包括2例急性肺源性心脏病死亡。388例肺动脉高压和/或右心室舒张末期压（RVEDP）升高的患者中出现6例并发症。这两例死亡发生在严重肺动脉高压和RVEDP升高的患者中。大多数严重心肺损伤患者对血管造影耐受良好。研究这组患者增加的风险是适度的，必须与患者的潜在治疗益处进行权衡。
Pulmonary arteriography is an invasive but relatively safe diagnostic procedure. It is generally believed that the presence of pulmonary hypertension is one risk factor that increases the likelihood of a major complication. To assess the magnitude of risk, the reports on 1,434 patients who underwent pulmonary arteriography were retrospectively reviewed, and the occurrence of complications in the 388 (27%) patients with pulmonary hypertension was noted. Major complications related to contrast material injection (excluding allergic reactions) occurred in 30 (2%) of the 1,434 examinations and included two deaths from acute cor pulmonale. Six complications occurred in the 388 patients with pulmonary hypertension and/or elevated right ventricular end-diastolic pressure (RVEDP). The two deaths occurred in patients with severe pulmonary hypertension and elevated RVEDP. Most patients with severe cardiopulmonary compromise tolerated angiography well. The increased risk of studying this group of patients is modest and must be weighed against the potential therapeutic benefits to the patient.